News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Experimental Johnson & Johnson (JNJ) Drug Works In Resistant Tuberculosis



6/4/2009 7:07:33 AM

Bookmark and Share

BOSTON, June 3 (Reuters) - An experimental drug that starves the bacteria responsible for tuberculosis makes conventional therapy five times more effective against drug-resistant TB, doctors reported on Wednesday.


Read at Reuters
Read at Wall Street Journal
Read at MedPageToday


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES